D. Huglo

5.2k total citations · 1 hit paper
120 papers, 3.6k citations indexed

About

D. Huglo is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, D. Huglo has authored 120 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 32 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Surgery. Recurrent topics in D. Huglo's work include Lymphoma Diagnosis and Treatment (21 papers), Medical Imaging Techniques and Applications (20 papers) and Neuroendocrine Tumor Research Advances (15 papers). D. Huglo is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Medical Imaging Techniques and Applications (20 papers) and Neuroendocrine Tumor Research Advances (15 papers). D. Huglo collaborates with scholars based in France, United Kingdom and Italy. D. Huglo's co-authors include M Steinling, Didier Leys, Jaap Valk, Patrick Vermersch, Philip Scheltens, Erik Ch. Wolters, Michaël Kuiper, H. C. Weinstein, Frederik Barkhof and C Proye and has published in prestigious journals such as Journal of Clinical Oncology, Blood and NeuroImage.

In The Last Decade

D. Huglo

110 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

1992 1.3k citations D. Huglo, M Steinling et al. profile →

Peers

Countries citing papers authored by D. Huglo

Since Specialization

Citations

This map shows the geographic impact of D. Huglo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Huglo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Huglo more than expected).

Fields of papers citing papers by D. Huglo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Huglo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Huglo. The network helps show where D. Huglo may publish in the future.

Co-authorship network of co-authors of D. Huglo

This figure shows the co-authorship network connecting the top 25 collaborators of D. Huglo. A scholar is included among the top collaborators of D. Huglo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Huglo. D. Huglo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism 2025 ·EJNMMI Research ·Marc C. Huisman, (unknown), Sandeep S.V. Golla, D. Huglo, Franck Morschhauser, Josée M. Zijlstra, (unknown), (unknown), (unknown), (unknown), Andrea Thiele, Daniëlle J. Vugts, (unknown), Gerben J.C. Zwezerijnen, Idris Bahce, C. Willemien Menke‐van der Houven van Oordt, Dhaval K. Shah, Yvonne W. S. Jauw, Ronald Boellaard	0
2	18‐ FDG PET in the Evaluation of Therapeutic Response of Necrotizing Otitis Externa 2025 ·The Laryngoscope ·(unknown), (unknown), D. Huglo, C. Baillet, (unknown), (unknown)	0
3	A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET 2024 ·NeuroImage ·(unknown), (unknown), Cécile Bordier, (unknown), (unknown), Thibaud Lebouvier, Florence Pasquier, D. Huglo, Franck Semah, Renaud Lopes	13
4	Evaluation of a convolution neural network for baseline total tumor metabolic volume on [18F]FDG PET in diffuse large B cell lymphoma 2023 ·European Radiology ·(unknown), (unknown), D. Huglo, C. Baillet, (unknown), Simon Dujardin, (unknown)	6
5	Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments 2022 ·La Presse Médicale ·Benjamin Chevalier, Arnaud Jannin, Stéphanie Espiard, E. Merlen, (unknown), Georges Lion, Marie‐Christine Vantyghem, D. Huglo, Christine Cortet‐Rudelli, C. Baillet	4
6	A new pharmacokinetic model for 90Y-ibritumomab tiuxetan based on 3-dimensional dosimetry 2018 ·Scientific Reports ·F. Morschhauser, (unknown), C. Baillet, Christine Barthélémy, (unknown), J. Fulcrand, Pierre Bigot, D. Huglo, Bertrand Décaudin, Nicolas Simon, (unknown)	2
7	Laparoscopic Partial ALPPS: Much Better Than ALPPS! 2018 ·Annals of Hepatology ·Stéphanie Truant, Mehdi El Amrani, C. Baillet, (unknown), Katia Lécolle, Olivier Ernst, Mohamed Hebbar, D. Huglo, François‐René Pruvot	23
8	Radium 223 dichloride for prostate cancer treatment 2017 ·Drug Design Development and Therapy ·Emmanuel Deshayes, M. Roumiguié, Constance Thibault, Philippe Beuzeboc, F. Cachin, Christophe Hennequin, D. Huglo, François Rozet, Diana Kassab‐Chahmi, Xavier Rébillard, Nadine Houédé	68
9	FDG PET/CT allowing detection and follow-up of tumor cell transplantation 2015 ·Annals of Nuclear Medicine ·(unknown), C. Baillet, (unknown), Nahid Tabibzadeh, Arnaud Scherpereel, Marie Frimat, Romain Perbet, Viviane Gnemmi, Christian Noël, D. Huglo	1
10	Radioimmunotherapy (90Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab 2015 ·American Journal of Transplantation ·Julien Rossignol, Louis Terriou, (unknown), Christophe Willekens, Bénédicte Hivert, Laurent Pascal, Romain Guièze, Ralf Ulrich Trappe, C. Baillet, D. Huglo, Franck Morschhauser	10
11	Coexistence of Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma and Graves' Hyperthyroidism 2013 ·European Thyroid Journal ·Mahdi Kamoun, Michèle d’Herbomez, C. Lemaire, A. Fayard, Rachel Desailloud, D. Huglo, Jean-Louis Wémeau	21
12	Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma. 2012 ·PubMed ·Ludovic Ferrer, (unknown), Caroline Bodet‐Milin, Steven Le Gouill, (unknown), (unknown), (unknown), Jill Tipping, D. Huglo, Philippe Carpentier, Tim Illidge, Françoise Kraeber‐Bodéré, F. Morschhauser, Manuel Bardiès	8
13	Dosimetry for fractionated ZevalinTM treatment as an initial therapy of follicular lymphoma. 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Ludovic Ferrer, Manuel Bardiès, Caroline Bodet‐Milin, Françoise Kraeber‐Bodéré, D. Huglo, Steven Le Gouill, (unknown), (unknown), Jill Tipping, (unknown), Tim Illidge, F. Morschhauser	1
14	A New Method for Volume Segmentation of PET Images, Based on Possibility Theory 2010 ·IEEE Transactions on Medical Imaging ·Anne‐Sophie Vignion‐Dewalle, Nacim Betrouni, Renaud Lopes, D. Huglo, Simon Stute, Maximilien Vermandel	36
15	Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma 2009 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Franck Morschhauser, Maximilien Vermandel, Nacim Betrouni, (unknown), M Steinling, D. Huglo	56
16	Valeurs de l'échoendoscopie et de la scintigraphie des récepteurs de la somatostatine dans la localisation pré-opératoire des insulinomes et gastrinomes. 2008 ·Gastroentérologie Clinique et Biologique ·Éric Mirallié, François Pattou, P. Malvaux, B Filoche, (unknown), V. Maunoury, Laurent Palazzo, J. Lefebvre, D. Huglo, Jean-Claude Paris, Bruno Carnaille, C Proye	0
17	An easy‐to‐use phantom and protocol for weekly PET quality assessment: A multicenter study 2008 ·Medical Physics ·Maximilien Vermandel, (unknown), Sébastien Hapdey, Anne Bol, Nacim Betrouni, Joël Daouk, (unknown), John A. Lee, (unknown), J. Rousseau, D. Huglo	5
18	Yttrium-90 ibritumomab tiuxetan (zevalin) induces high response rates in previously treated patients with diffuse large B cell lymphoma (DLBCL) 2005 ·Annals of Oncology ·Franck Morschhauser, D. Huglo, Giovanni Martinelli, Giovanni Paganelli, Pier Luigi Zinzani, (unknown), Anna Marina Liberati, Tim Illidge, Nöel Milpied, J. Kalmus, (unknown), (unknown), Roy Marcus	7
19	Devenir des masses surrénaliennes non opérées chez 126 patients suivis de 1986 à 1999 2001 ·Annales de Chirurgie ·Éric Mirallié, (unknown), François Pattou, Olivier Ernst, D. Huglo, Bruno Carnaille, C Proye	7
20	TUMOUR SIZE: THE ONLY PREDICTIVE FACTOR FOR ¹³¹I MIBG UPTAKE IN PHAEOCHROMOCYTOMA AND PARAGANGLIOMA 1999 ·Australian and New Zealand Journal of Surgery ·Hieu Nguyen, C Proye, Bruno Carnaille, Frédéric Combemale, François Pattou, D. Huglo	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact